产品简要
公司名称 :
BioLegend
其他品牌 :
Babco, Signet, Sternberger Monoclonals, Senetek, Covance
产品类型 :
抗体
产品名称 :
PE抗人类CD340(v-erb-b2成红细胞白血病病毒致瘤基因2/HER-2)
目录 :
324406
规格 :
100试验
价格 :
240美元
克隆性 :
单克隆
宿主 :
小鼠
共轭标签 :
PE
克隆名称 :
24D2
反应物种 :
人类
应用 :
流式细胞仪
更多信息或购买 :
文章摘录数: 12
出版应用/物种/样本/稀释参考文献
  • 流式细胞仪; 人类; 图 2
Kan S, Koido S, Okamoto M, Hayashi K, Ito M, Kamata Y, et al. Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cells. BMC Cancer. 2015;15:726 pubmed 出版商
  • 流式细胞仪; 人类; 图 4
Kan S, Koido S, Okamoto M, Hayashi K, Ito M, Kamata Y, et al. Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansine. Oncol Rep. 2015;34:504-10 pubmed 出版商
Robichaux J, Elamin Y, Vijayan R, Nilsson M, Hu L, He J, et al. Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity. Cancer Cell. 2019;36:444-457.e7 pubmed 出版商
Baccelli I, Gareau Y, Lehnertz B, Gingras S, Spinella J, Corneau S, et al. Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia. Cancer Cell. 2019;36:84-99.e8 pubmed 出版商
Pahuja K, Nguyen T, Jaiswal B, Prabhash K, Thaker T, Senger K, et al. Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain Mutations. Cancer Cell. 2018;34:792-806.e5 pubmed 出版商
Baldassarre T, Truesdell P, Craig A. Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers. Breast Cancer Res. 2017;19:110 pubmed 出版商
Castagnoli L, Ghedini G, Koschorke A, Triulzi T, Dugo M, Gasparini P, et al. Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer. Oncogene. 2017;36:1721-1732 pubmed 出版商
. ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma. J Natl Cancer Inst. 2016;108: pubmed 出版商
Vishnoi M, Peddibhotla S, Yin W, T Scamardo A, George G, Hong D, et al. The isolation and characterization of CTC subsets related to breast cancer dormancy. Sci Rep. 2015;5:17533 pubmed 出版商
Meschenmoser K, Kim Y, Franken S, Nowak M, Feldmann G, Bendas G, et al. Targeting cancer with a bi-functional peptide: in vitro and in vivo results. In Vivo. 2013;27:431-42 pubmed
Lange T, Nentwich M, Lüth M, Yekebas E, Schumacher U. Trastuzumab has anti-metastatic and anti-angiogenic activity in a spontaneous metastasis xenograft model of esophageal adenocarcinoma. Cancer Lett. 2011;308:54-61 pubmed 出版商
Li Z, Ling L, Liu X, Laus R, Delcayre A. A flow cytometry-based immuno-titration assay for rapid and accurate titer determination of modified vaccinia Ankara virus vectors. J Virol Methods. 2010;169:87-94 pubmed 出版商
产品信息
抗原 :
CD340
Apps. Abbrev. :
流式细胞仪
目录 :
324406
克隆 :
24D2
产品 :
PE抗人类CD340(v-erb-b2成红细胞白血病病毒致瘤基因2/HER-2)
抗体亚型 :
Mouse IgG1, κ
其他名称 :
HER2/erbB2, tyrosine kinase cell surface receptor HER2, oncogene ERBB2, oncogene NGL, neuroblastoma- or glioblastoma-derived, HER-2
规格 :
100试验
价格(美元) :
240美元
反应物种 :
人类
克隆性 :
单克隆
宿主 :
小鼠
共轭标签/标签/标记 :
PE
免疫原 :
NIH-3T3 transfected with human HER-2
更多信息或购买 :
公司信息
BioLegend
8999 BioLegend Way
San Diego, CA 92121
customerserv@biolegend.com
https://www.biolegend.com
1-858-455-9588
公司总部: 美国
Biolegend公司为生物医学研究提供顶级的抗体及试剂产品,旨在加速生命科学领域的研发工作。